Brainsway Stock

Brainsway Market capitalization 2024

Brainsway Market capitalization

14.15 B USD

Ticker

BWAY.TA

ISIN

IL0011007189

WKN

A0NDVW

In 2024, Brainsway's market cap stood at 14.15 B USD, a 143.34% increase from the 5.82 B USD market cap in the previous year.

The Brainsway Market capitalization history

YEARMarket Capitalization (undefined USD)
20234.91
20229.21
202113.51
20208.35
201910.86
20189.22
20177.33
20166.67
201510.88
201419.04
201318.72
20127.65
2011-
2010-
2009-
2008-
2007-
2006-

Brainsway Aktienanalyse

What does Brainsway do?

Brainsway Ltd is a leading provider of non-invasive brain stimulation solutions based in Jerusalem, Israel. The company was founded in 2003 and has since become a major player in the field of neurological disorders. Brainsway's business model includes the development, production, and marketing of innovative brain stimulation solutions. The company's products are based on transcranial magnetic stimulation (TMS), a proven technology for treating neurological disorders. TMS involves generating brain stimulation through a non-invasive method, using gentle magnetic pulses directed at the targeted area of the brain to specifically influence brain activity. The company is divided into three business areas: psychiatry, neurology, and rehabilitation. The psychiatry area includes the treatment of disorders such as depression, obsessive-compulsive disorder, addiction, and schizophrenia. The neurology area, on the other hand, focuses on disorders such as Parkinson's disease, Alzheimer's disease, and epilepsy. The rehabilitation area is used for anatomical rehabilitation and stroke rehabilitation and is the newest product of Brainsway. Each area includes a variety of products tailored to the individual needs of users. One of Brainsway's most well-known products is the Deep TMS Stimulator, which was specifically developed for the treatment of depression. The Deep TMS therapy has been clinically tested and identified as an effective method for treating depression, obsessive-compulsive disorder, and ADHD. The device has already been marketed in over twenty countries. Brainsway is also a leader in the treatment of Parkinson's disease with TMS. Clinical studies have shown that the application of Brainsway TMS in Parkinson's patients reduces symptoms by almost 50%. The benefits of TMS in Parkinson's include improved motor function, increased quality of life, and a reduction in the frequency of falls. The company has established collaborations with major pharmaceutical companies and research institutions. Brainsway works closely with scientific institutions to continuously develop and improve therapies and products. Brainsway Ltd is an innovative company that is a leader in the field of non-invasive brain stimulation. Brainsway's products have proven to be effective in treating a variety of disorders, and the company has a promising future in researching and developing new therapies. Brainsway ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Market capitalization Details

Exploring Brainsway's Market Capitalization

Brainsway's market capitalization represents the total dollar market value of the company’s outstanding shares of stock. It is calculated by multiplying the company's shares outstanding by the current market price of one share. This metric is a vital indicator of a company’s size, strength, and overall market value.

Year-to-Year Comparison

A yearly comparison of Brainsway's market capitalization provides investors and analysts insights into its growth and valuation trends. An increase signifies market confidence and business expansion, while a decrease may point towards declining market value or business contractions.

Impact on Investments

Brainsway's market capitalization plays a pivotal role in investment decisions. It aids investors in assessing the company's risk and return profiles. Larger companies are often considered more stable but may offer lower growth potential, while smaller companies might offer significant growth prospects but come with higher risk.

Interpreting Market Capitalization Fluctuations

Variations in Brainsway’s market capitalization can be attributed to several factors, including changes in stock price, outstanding shares, and market sentiment. Understanding these fluctuations helps investors evaluate the company's current standing and future potential in the competitive landscape.

Frequently Asked Questions about Brainsway stock

What is the current Brainsway market capitalization?

The current market capitalization of Brainsway is 14.15 B USD.

What is market capitalization?

The market capitalization (German: Marktkapitalisierung, English: market capitalization, abbreviated as market cap, also known as stock exchange capitalization or market value) is the calculated total value of all shares of a publicly traded company like Brainsway.

How has the market capitalization of Brainsway developed in recent years?

The market capitalization of Brainsway has increased/decreased by 143.34% compared to the previous year.

What does market capitalization mean for investors?

The market capitalization of a company reflects the current market consensus on the value of the equity of a publicly traded company.

Why is market capitalization an important indicator for investors?

The market capitalization of a company reflects the current market consensus on the value of a publicly traded company's equity. It is determined by the supply and demand for the company's shares. Market capitalization is thus significantly influenced by expectations in the stock market regarding the future earnings power of the company, and as such, it can undergo significant fluctuations.

Why does the market capitalization fluctuate?

The market capitalization fluctuates along with the stock price, as the market capitalization is calculated based on the current price and the number of outstanding shares.

What role does market capitalization play in the valuation of Brainsway?

In order to compare the value of companies, it is helpful to consider not only the market capitalization but also the net debt of a company. A potential buyer of the entire company would also acquire the debts of the company. The enterprise value is the total value of a company or a stock corporation. The net financial indebtedness of the company is added to the market capitalization.

Does the market capitalization influence the performance of Brainsway?

There is no verifiable long-term evidence or study that stocks with a specific market capitalization (whether Mega/Large/Mid/Small Cap) would consistently yield significantly higher returns than others. There are occasional small studies (few stocks, short investment period) suggesting that certain classes may perform better or have higher risk, but none of them are 1. conclusive (cause-effect relationship is unclear, experiment is not repeatable) or 2. generalizable (generalization is not possible due to small sample size and time period).

Does the market capitalization of Brainsway have an influence on indices?

Some stock indices use market capitalization as index weighting. Stocks with a higher market capitalization are also weighted higher in the index. This is in contrast to equally weighted indices (all stocks have the same weighting) and free float weighted indices (market capitalization weighting, but only with the number of shares in free float).

How much dividend does Brainsway pay?

Over the past 12 months, Brainsway paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Brainsway is expected to pay a dividend of 0 USD.

What is the dividend yield of Brainsway?

The current dividend yield of Brainsway is .

When does Brainsway pay dividends?

Brainsway pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Brainsway?

Brainsway paid dividends every year for the past 0 years.

What is the dividend of Brainsway?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Brainsway located?

Brainsway is assigned to the 'Health' sector.

Wann musste ich die Aktien von Brainsway kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Brainsway from 9/27/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 9/27/2024.

When did Brainsway pay the last dividend?

The last dividend was paid out on 9/27/2024.

What was the dividend of Brainsway in the year 2023?

In the year 2023, Brainsway distributed 0 USD as dividends.

In which currency does Brainsway pay out the dividend?

The dividends of Brainsway are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Brainsway

Our stock analysis for Brainsway Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Brainsway Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.